Table 2.

Baseline data

Parameter	Total	Cilnidipine	Amlodipine
Serum Cr (mg/dL) eGFR* (mL/min/1.73m2) Stage of CKD** Stage 1 Stage 2 Stage 3 Stage 4 HbA1c (%) Casual blood glucose (mg/dL) Systolic BP (mmHg) Diastolic BP (mmHg) PR (bpm)	0.77±0.20 72.68±17.78 50 235 78 2 6.43±0.69 139.34±45.31 145.95±12.16 80.80±10.04 74.98±10.63	0.77±0.18 71.85±15.85 20 118 40 1 6.44±0.70 137.19±44.94 146.56±12.72 81.46±10.27 74.61±10.36	0.78±0.21 73.48±19.46 30 117 38 1 6.41±0.68 141.41±45.68 145.37±11.59 80.17±9.80 75.33±10.89

Data are shown as the no. of patients (%) or the mean ± SD. Abbreviations: Cr: creatinine, eGFR: estimated glomerular filtration rate, CKD: chronic kidney disease, HbA1c: hemoglobin A1c, BP: blood pressure, PR: pulse rate. *eGFR: calculated with the “Modified Diet in Renal Disease (MDRD) formula” modified by the Japanese Society of Nephrology ²¹. **Stage of CKD: defined according to the Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2009 ²⁰.